Ethical and safety issues of stem cell-based therapy part 10

Stem cell 5


Clinical trial that investigates potential of human embryonic stem cell-based therapy for the treatment of diabetes mellitus is opened and recruitment of patients has begun in 2014. The goal of this study is to evaluate the safety and efficacy of VC-01, an implant containing human embryonic stem cells derived pancreatic progenitor cells encapsulated by an immune protecting device, which would allow the cells to proliferate and differentiate into mature β-cells in vivo without the possibility of immune rejection.

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s